Gene Biotherapeutics, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/20 FY 2020 – amended

ended 12/31/20 FY 2020

ended 09/30/20 Q3

ended 06/30/20 Q2

ended 03/31/20 Q1

Prospectuses and Registrations Filter

Commission order revoking registration

Removal from listing

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Ownership Filter

Jemapete Christopher J

Sabby Management, LLC

Jemapete Christopher J

Jemapete Christopher J

Jemapete Christopher J

News Filter

Change in Certifying Accountant

Change in Certifying Accountant

Announces Director Retirement Following 16 Years of Distinguished Service

Partners With Fujifilm Diosynth Biotechnologies to Manufacture Generx [Ad5fgf-4] Phase 3 Angiogenic Gene Therapy Product Candidate for Refractory Angina

Secures Investment From Nostrum Pharmaceuticals, LLC

Proxies Filter

Definitive proxy

Definitive proxy

Additional info about upcoming vote

Additional info about upcoming vote

Additional info about upcoming vote

Other Filter

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC